<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report" xml:lang="en">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Neurol</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Neurol</journal-id>
      <journal-title-group>
        <journal-title>BMC Neurology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1471-2377</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">23020225</article-id>
      <article-id pub-id-type="pmc">3570427</article-id>
      <article-id pub-id-type="publisher-id">1471-2377-12-112</article-id>
      <article-id pub-id-type="doi">10.1186/1471-2377-12-112</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Recurrent aseptic meningitis in association with Kikuchi-Fujimoto disease: case report and literature review</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes" id="A1">
          <name>
            <surname>Komagamine</surname>
            <given-names>Tomoko</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>tkoma@dokkyomed.ac.jp</email>
        </contrib>
        <contrib contrib-type="author" id="A2">
          <name>
            <surname>Nagashima</surname>
            <given-names>Takahide</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>tnagashi@dokkyomed.ac.jp</email>
        </contrib>
        <contrib contrib-type="author" id="A3">
          <name>
            <surname>Kojima</surname>
            <given-names>Masaru</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>k-masaru@dokkyomed.ac.jp</email>
        </contrib>
        <contrib contrib-type="author" id="A4">
          <name>
            <surname>Kokubun</surname>
            <given-names>Norito</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>kokubun@dokkyomed.ac.jp</email>
        </contrib>
        <contrib contrib-type="author" id="A5">
          <name>
            <surname>Nakamura</surname>
            <given-names>Toshiki</given-names>
          </name>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>dr.nakamura@amakusa.ecnet.jp</email>
        </contrib>
        <contrib contrib-type="author" id="A6">
          <name>
            <surname>Hashimoto</surname>
            <given-names>Kenich</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>k073796@yahoo.co.jp</email>
        </contrib>
        <contrib contrib-type="author" id="A7">
          <name>
            <surname>Kimoto</surname>
            <given-names>Kazuhito</given-names>
          </name>
          <xref ref-type="aff" rid="I4">4</xref>
          <email>k-kimoto@qa2.so-net.ne.jp</email>
        </contrib>
        <contrib contrib-type="author" id="A8">
          <name>
            <surname>Hirata</surname>
            <given-names>Koichi</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>hirata@dokkyomed.ac.jp</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Department of Neurology, Dokkyo Medical University, 880 Kitakobayashi, Mibu, Shimotsuga, Tochigi, 321-0293, Japan</aff>
      <aff id="I2"><label>2</label>Department of Anatomic and Diagnostic Pathology, Dokkyo Medical University, Tochigi, Japan</aff>
      <aff id="I3"><label>3</label>Department of Neurology, Amakusa Rehabilitation Hospital, Saitama, Japan</aff>
      <aff id="I4"><label>4</label>Department of Neurology, Keiju General Hospital, Ishikawa, Japan</aff>
      <pub-date pub-type="collection">
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>29</day>
        <month>9</month>
        <year>2012</year>
      </pub-date>
      <volume>12</volume>
      <fpage>112</fpage>
      <lpage>112</lpage>
      <history>
        <date date-type="received">
          <day>2</day>
          <month>5</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>26</day>
          <month>9</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9;2012 Komagamine et al.; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2012</copyright-year>
        <copyright-holder>Komagamine et al.; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="http://www.biomedcentral.com/1471-2377/12/112"/>
      <abstract>
        <sec>
          <title>Background</title>
          <p>Kikuchi Fujimoto disease (KFD), or histiocytic necrotising lymphadenitis, is a benign and self-limiting condition characterised by primarily affecting the cervical lymph nodes. Recurrent aseptic meningitis in association with KFD is extremely rare and remains a diagnostic challenge.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>We report a 28-year-old man who presented 7 episodes of aseptic meningitis associated with KFD over the course of 7 years. Histopathological findings of enlarged lymph nodes led to the diagnosis of KFD. The patient&#x2019;s headache and lymphadenopathy spontaneously resolved without any sequelae.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>A diagnosis of KFD should be considered when enlarged cervical lymph nodes are observed in patients with recurrent aseptic meningitis. A long-term prognosis remains uncertain, and careful follow-up is preferred.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>Recurrent aseptic meningitis</kwd>
        <kwd>Kikuchi-Fujimoto disease</kwd>
        <kwd>Histiocytic necrotising lymphadenitis</kwd>
        <kwd>SLE</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Kikuchi-Fujimoto disease (KFD), or histiocytic necrotising lymphadenitis, is recognised as a benign lymphadenopathy that has acute or sub-acute onset and is primarily localised within the cervical lymph nodes. KFD has various extranodal manifestations, including skin lesions, gastrointestinal symptoms or splenomegaly [<xref ref-type="bibr" rid="B1">1</xref>]. Neurological complications, including aseptic meningitis, mononeuritis multiplex or acute cerebellar ataxia, are not common [<xref ref-type="bibr" rid="B2">2</xref>], and a meta-analysis of 244 KFD cases in 181 published case reports demonstrated 11% of incidence of neurological involvements [<xref ref-type="bibr" rid="B3">3</xref>]. The most common neurological complication is aseptic meningitis, which is observed in 2.8-9.8% of KFD cases [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>]. KFD usually resolves spontaneously within a few months, and the recurrence rate is 3-4% [<xref ref-type="bibr" rid="B6">6</xref>]. Recurrent aseptic meningitis associated with KFD is an extremely rare condition, and only 4 sporadic cases have been reported [<xref ref-type="bibr" rid="B7">7</xref>-<xref ref-type="bibr" rid="B10">10</xref>]. In this study, we describe a KFD patient who presented with 7 episodes of recurrent meningitis. We also investigate the clinical and laboratory features of 4 patients previously reported in the literature.</p>
    </sec>
    <sec>
      <title>Case presentation</title>
      <p>A 28-year-old Japanese man was admitted to our hospital because of headache and remittent fever that had lasted for 12 days after a solar exposure. The patient had a history of atopic dermatitis from age 2 and had 5 previous episodes of aseptic meningitis with an undetermined aetiology between the ages of 21 and 27 years-old (Figure <xref ref-type="fig" rid="F1">1</xref>).</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p><bold>Clinical course of the </bold><bold>patient.</bold> The patient had his first meningitis episode at 21 years of age. Two resolutions and exacerbations occurred within the following 3 months. He had the fourth to seventh episodes of meningitis between 27 and 28 years of age. In each episode the patient&#x2019;s symptoms and abnormal cerebrospinal fluids were spontaneously resolved. Lymphadenopathy was evident both in the attacks at age 27 and age 28.</p>
        </caption>
        <graphic xlink:href="1471-2377-12-112-1"/>
      </fig>
      <p>Upon admission, day 12, the patient was alert and had pyrexia of 39&#xB0;C and severe headache with positive Kernig's Sign. The palpable tender lymph nodes with 10 mm in size were present on the right posterior neck, similar to a recent meningitis episode. No other neurological deficits were noted. Laboratory analysis revealed no abnormalities in the patient&#x2019;s complete blood cell count or liver and thyroid function tests. His serum CRP and IgE levels were elevated, measuring 2.5 mg/dL (normal, &lt;0.3) and 6950 mg/dL (normal, &lt; 295), respectively. The cerebrospinal fluid (CSF) examination showed a crystal clear appearance and pleocytosis of 27 cells/mm<sup>3</sup> (97% mononuclear cells) with a protein concentration of 31 mg/dL (normal, &lt; 45). The CSF glucose/glycaemia ratio was 0.86 with sterile bacterial, tuberculosis and fungal cultures. A CSF polymerase chain reaction (PCR) assay for the herpes simplex virus (HSV) was negative. The patient recovered after the administration of non-steroidal anti-inflammatory drugs as a symptomatic treatment and was discharged in remission on day 26.</p>
      <p>Subsequently, the patient was re-admitted on day 37 with headache and remittent fever. He was febrile with re-appearance of Kernig's Sign. The posterior cervical lymph nodes were enlarged and tender bilaterally. Additionally, the patient also had oral aphthae and skin rashes on his trunk along with atopic dermatitis. He was alert, and no focal neurological deficit was noted. A complete blood count revealed leukocytopaenia (2.7 x 10<sup>9</sup>/L) with 1% of atypical lymphocytes. A biochemical examination showed abnormal levels with LDH 729 U/L (normal, &lt;220), ferritin 2660 ng/mL (normal, 25&#x2013;280) and an erythrocyte sedimentation rate of 59 mm/h (normal, &lt;10). IgE and CRP assays exhibited higher levels than those of previous tests, with values of 10400 mg/dL and CRP 6.5 mg/dL being observed, respectively. Serum anti-nuclear and anti-neutrophil cytoplasmic antibodies and rheumatoid factor were within normal range. The complement 3 level was slightly elevated with 194 mg/dL (normal, 65&#x2013;135). Human leukocyte antigen B51 was negative. The evidence of other infectious agents, such as human hepatitis viruses B and C, human T-cell lymphoma virus-1, syphilis, HSV-1 and 2, varicella-zoster virus (VZV), cytomegalovirus, Epstein-Barr virus (EBV), human herpes virus type 6 (HHV-6) and toxoplasmosis (<italic>Toxoplasma gondii)</italic> were not detected. A CSF examination revealed a pleocytosis of 16 cells/mm<sup>3</sup> (97% mononuclear cells) and a protein concentration of 28 mg/dL, as well as a CSF glucose/glycaemia ratio of 0.75 with sterile bacterial, tuberculosis and fungal cultures. CSF PCRs for HSV, HHV-6, VZV and tuberculosis were negative. The patient&#x2019;s CSF IgE level was not elevated (19 IU/ml, IgE index 0.03). Splenomegaly was present upon abdominal echograph. No enlargement of deep lymph nodes was detected using computed tomography. Moreover, brain magnetic resonance imaging showed no structural abnormalities.</p>
      <p>An excisional biopsy of the involved posterior cervical lymph nodes was performed. The affected lymph nodes showed focal paracortical necrotic lesions (Figure <xref ref-type="fig" rid="F2">2</xref>A). Under a high power field, the lesion had abundant karyorrhectic debris with apoptotic bodies, numerous histiocytes and large lymphoid cells and scattered fibrin (Figure <xref ref-type="fig" rid="F2">2</xref>B). However, there were no neutrophils in the lesion. A portion of the phagocytic macrophage had crescent nuclei. Moreover, Giemsa stained sections highlighted the plasmacytoid dendritic cells clusters at the margins of the necrotic foci (Figure <xref ref-type="fig" rid="F2">2</xref>C). Immunohistochemical study demonstrated that the histiocytes expressed CD68 and myeloperoxidase (Figure <xref ref-type="fig" rid="F2">2</xref>D, E). Based on these pathological findings, the diagnosis of KFD was made.</p>
      <fig id="F2" position="float">
        <label>Figure 2</label>
        <caption>
          <p><bold>Histopathological findings of affected </bold><bold>lymph node. A</bold>: In a low-power field, the affected lymph node showed discreet areas of necrosis paracortex (Hematoxylin-eosin stain, 10X). <bold>B</bold>: In a high-power field, the lesion demonstrated abundant karyorrhectic debris with apoptosis bodies and numerous histiocytes and large lymphoid cells (arrows). There were no neutrophils in the lesion (Hematoxylin-eosin stain, 100X). <bold>C</bold>: Giemsa stained section highlighted the plasmacytoid dendritic cells cluster (arrowheads) at the margins of the necrotic foci (may-Giemsa stain, 100X). <bold>D</bold>: Immunostain demonstrated that many histiocytes in the necrotic area were positive for myeloperoxidase (60X). <bold>E</bold>: Portions of the hystiocytes were stained with CD68 (60X). The scale bars in each panel indicate 10 &#x3BC;m, except for panel A (50 &#x3BC;m).</p>
        </caption>
        <graphic xlink:href="1471-2377-12-112-2"/>
      </fig>
      <p>The patient did not receive medication during his second admission. Also, his symptoms and CSF parameters spontaneously resolved within two weeks. His enlarged lymph nodes gradually decreased in size. The patient was discharged in remission on day 49, and he remains headache-free after 28 months of follow-up.</p>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>Since KFD was first described by both a pathologist and physician independently in 1972 [<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B12">12</xref>], the aetiology of KFD remains largely unknown. The histopathological features of affected lymph nodes in KFD are, on occasion, notably similar to those of SLE [<xref ref-type="bibr" rid="B13">13</xref>]. Therefore, pathogenic linkage between the two disorders has been proposed [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B13">13</xref>]. Infectious agents, including toxoplasmosis, EBV, and HHV-6, have also been considered as possible causal agents, but several studies have failed to confirm their association [<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B14">14</xref>]. There is no specific treatment for KFD because of its unknown aetiology. In general, the patients are treated symptomatically; for example, relief of local and systemic complaints with the use of analgesics, antipyretics and rest [<xref ref-type="bibr" rid="B13">13</xref>]. Furthermore, corticosteroids may be effective in severe cases or for a relapsing condition [<xref ref-type="bibr" rid="B1">1</xref>].</p>
      <p>The aseptic meningitis associated with KFD was first reported in 1979 [<xref ref-type="bibr" rid="B4">4</xref>]. Today, 18 sporadic case reports have been documented in MEDLINE and Japan Medical Abstracts Society-website, with 4 of them reporting recurrence of meningitis [<xref ref-type="bibr" rid="B7">7</xref>-<xref ref-type="bibr" rid="B10">10</xref>]. The clinical profiles of our patient and the 4 patients reviewed in the literature are shown in Table <xref ref-type="table" rid="T1">1</xref>. In all 5 cases the symptoms resolved within several months. Corticosteroids were administered in 3 out of the 5 patients. All of the 3 did not have early post-treatment relapse after receiving steroids. Steroid treatment may be beneficial for recurrent KFD with aseptic meningitis, although recommendation of steroid administration requires further investigation. </p>
      <table-wrap position="float" id="T1">
        <label>Table 1</label>
        <caption>
          <p>
            <bold>The clinical features of </bold>
            <bold>recurrent aseptic meningitis cases </bold>
            <bold>with Kikuchi-Fujimoto disease</bold>
          </p>
        </caption>
        <table frame="hsides" rules="groups" border="1">
          <colgroup>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
          </colgroup>
          <thead valign="top">
            <tr>
              <th align="left">
                <bold>Case and reference number</bold>
              </th>
              <th align="left"><bold>1</bold>[<xref ref-type="bibr" rid="B7">7</xref>]</th>
              <th align="left"><bold>2</bold>[<xref ref-type="bibr" rid="B8">8</xref>]</th>
              <th align="left"><bold>3</bold>[<xref ref-type="bibr" rid="B9">9</xref>]</th>
              <th align="left"><bold>4</bold>[<xref ref-type="bibr" rid="B10">10</xref>]</th>
              <th align="left">
                <bold>5 (present case)</bold>
              </th>
            </tr>
          </thead>
          <tbody valign="top">
            <tr>
              <td align="left" valign="bottom">Age/gender<hr/></td>
              <td align="left" valign="bottom">21/M<hr/></td>
              <td align="left" valign="bottom">12/F<hr/></td>
              <td align="left" valign="bottom">29/M<hr/></td>
              <td align="left" valign="bottom">35/F<hr/></td>
              <td align="left" valign="bottom">28/M<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Meningeal sign<hr/></td>
              <td align="left" valign="bottom">-<hr/></td>
              <td align="left" valign="bottom">+<hr/></td>
              <td align="left" valign="bottom">-<hr/></td>
              <td align="left" valign="bottom">+<hr/></td>
              <td align="left" valign="bottom">+<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Maximum Cerebrospinal fluid cell count/mm<sup>3</sup><hr/></td>
              <td align="left" valign="bottom">178<hr/></td>
              <td align="left" valign="bottom">100<hr/></td>
              <td align="left" valign="bottom">63<hr/></td>
              <td align="left" valign="bottom">59<hr/></td>
              <td align="left" valign="bottom">137<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Duration of the meningitis episode<hr/></td>
              <td align="left" valign="bottom">10 days<hr/></td>
              <td align="left" valign="bottom">10 days<hr/></td>
              <td align="left" valign="bottom">10-30 days<hr/></td>
              <td align="left" valign="bottom">10 days<hr/></td>
              <td align="left" valign="bottom">10 &#x2013; 20 days<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Interval between each episode<hr/></td>
              <td align="left" valign="bottom">1 month<hr/></td>
              <td align="left" valign="bottom">1 week<hr/></td>
              <td align="left" valign="bottom">11 years<hr/></td>
              <td align="left" valign="bottom">5 months, 11 months<hr/></td>
              <td align="left" valign="bottom">1 week to 6 years<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Coexisting conditions<hr/></td>
              <td align="left" valign="bottom">High titre of anti-Toxoplasma antibody<hr/></td>
              <td align="left" valign="bottom">-<hr/></td>
              <td align="left" valign="bottom">Elevation of serum IgE<hr/></td>
              <td align="left" valign="bottom">High titre of antinuclear antibody<hr/></td>
              <td align="left" valign="bottom">Elevation of serum IgE<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Steroid Use<hr/></td>
              <td align="left" valign="bottom">-<hr/></td>
              <td align="left" valign="bottom">Oral prednisolone,<hr/></td>
              <td align="left" valign="bottom">Intravenous methyl prednisolone,<hr/></td>
              <td align="left" valign="bottom">Oral prednisolone,<hr/></td>
              <td align="left" valign="bottom">-<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
              <td align="left" valign="bottom">1 mg/kg<hr/></td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
              <td align="left" valign="bottom">40 mg/day<hr/></td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
            </tr>
            <tr>
              <td align="left">&#xA0;</td>
              <td align="left">&#xA0;</td>
              <td align="left">&#xA0;</td>
              <td align="left">1000 mg/day</td>
              <td align="left">&#xA0;</td>
              <td align="left">&#xA0;</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>Our patient had concurrent atopic dermatitis, and his serum IgE levels were elevated along with exacerbation from meningitis and lymphadenitis. Because IgE was not elevated in the CSF, his high serum IgE titre did not appear to play a pathogenic role in aseptic meningitis. A prior case with an elevation of serum IgE in recurrent aseptic meningitis with KFD has been reported [<xref ref-type="bibr" rid="B9">9</xref>]. In this study, we speculate that IgE elevation may be reflected the immunostimulatory condition that was activated upon KFD in a patient with atopic dermatitis. A striking histopathological feature of KFD is the clustering of the plasmacytoid dendritic cells at the margins of the necrotic foci of affected lymph node [<xref ref-type="bibr" rid="B1">1</xref>]. Plasmacytoid dendritic cells are known to produce type I interferon in response to viral infection and to induce human memory B cells to differentiate into plasma cells and produce immunoglobulin [<xref ref-type="bibr" rid="B15">15</xref>]. Type I interferon is known as a potential pathogenic agent in the SLE-related neurological involvement [<xref ref-type="bibr" rid="B16">16</xref>]. Moreover, the high titre of antinuclear antibodies had also been observed in another case [<xref ref-type="bibr" rid="B10">10</xref>]. The progression of recurrent aseptic meningitis with KFD may stem from pathogenic association with SLE or other autoimmune disorders. Further studies are necessary to clarify this hypothesis.</p>
    </sec>
    <sec sec-type="conclusions">
      <title>Conclusions</title>
      <p>Recurrent aseptic meningitis with KFD is extremely rare condition. However, awareness of KFD as the differential diagnosis for meningitis might assist with diagnosis of patients presenting with lymphadenopathy. Early excisional lymph node biopsy should be considered to avoid unnecessary treatments. Temporary corticosteroid treatment may be beneficial to patients that present with recurrent meningitis with KFD, although this treatment&#x2019;s long-term efficacy remains uncertain. Because of the association with SLE, patient follow-up visit is necessary upon subsequent development of symptoms.</p>
      <sec>
        <title>Consent</title>
        <p>Written informed consent was obtained from the patient for the publication of this case report.</p>
      </sec>
      <sec>
        <title>Ethics approval</title>
        <p>The study was approved by the Human Ethics Review Committee of Dokkyo Medical University.</p>
      </sec>
    </sec>
    <sec>
      <title>Abbreviations</title>
      <p>CSF: Cerebrospinal fluid; EBV: Epstein-Barr virus; HHV-6: Human herpes virus type 6; HSV: Herpes simplex virus; KFD: Kikuchi Fujimoto disease; PCR: Polymerase chain reaction; SLE: Systemic lupus erythematosus; VZV: Varicella-zoster virus.</p>
    </sec>
    <sec>
      <title>Competing interest</title>
      <p>The authors declare that they have no competing of interests.</p>
    </sec>
    <sec>
      <title>Authors&#x2019; contributions</title>
      <p>KT and NT had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Study concept, design, and interpretation: KT and NT. Collection and analysis of data: KT, NT, KK and HK. Critical revision of the manuscript: NT and KN. Pathological interpretation: KM. Figure arrangement: KN and KT. All authors read and approved the final manuscript.</p>
    </sec>
    <sec>
      <title>Pre-publication history</title>
      <p>The pre-publication history for this paper can be accessed here:</p>
      <p>
        <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2377/12/112/prepub">http://www.biomedcentral.com/1471-2377/12/112/prepub</ext-link>
      </p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hutchinson</surname>
            <given-names>CB</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>E</given-names>
          </name>
          <article-title>Kikuchi-Fujimoto disease</article-title>
          <source>Arch Pathol Lab Med</source>
          <year>2010</year>
          <volume>134</volume>
          <fpage>289</fpage>
          <lpage>293</lpage>
          <pub-id pub-id-type="pmid">20121621</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Moon</surname>
            <given-names>JS</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>GII</given-names>
          </name>
          <name>
            <surname>Koo</surname>
            <given-names>YH</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>HS</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>WC</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>OJ</given-names>
          </name>
          <name>
            <surname>Oh</surname>
            <given-names>SH</given-names>
          </name>
          <article-title>Kinetic tremor and cerebellar ataxia as initial manifestations of Kikuchi-Fujimoto's disease</article-title>
          <source>J Neurol Sci</source>
          <year>2009</year>
          <volume>277</volume>
          <fpage>181</fpage>
          <lpage>183</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jns.2008.10.021</pub-id>
          <pub-id pub-id-type="pmid">19027125</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Kucukardali</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Solmazgul</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Kunter</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Oncul</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Yildirim</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kaplan</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Kikuchi-Fujimoto disease: analysis of 244 cases</article-title>
          <source>Clin Rheumato</source>
          <year>2007</year>
          <volume>26</volume>
          <fpage>50</fpage>
          <lpage>54</lpage>
          <pub-id pub-id-type="doi">10.1007/s10067-006-0230-5</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Sato</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Kuno</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Oizumi</surname>
            <given-names>K</given-names>
          </name>
          <article-title>Histiocytic necrotizing lymphadenitis (Kikuchi's disease) with aseptic meningitis</article-title>
          <source>J Neurol Sci</source>
          <year>1999</year>
          <volume>163</volume>
          <fpage>187</fpage>
          <lpage>191</lpage>
          <pub-id pub-id-type="doi">10.1016/S0022-510X(99)00037-4</pub-id>
          <pub-id pub-id-type="pmid">10371083</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Nakamura</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Imamura</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Yanagizawa</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Suganuma</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Ajizawa</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Medical study of 69 cases as Kikuchi's disease</article-title>
          <source>Kansenshogaku Zasshi</source>
          <year>2009</year>
          <volume>83</volume>
          <fpage>363</fpage>
          <lpage>368</lpage>
          <pub-id pub-id-type="pmid">19697871</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Kuo</surname>
            <given-names>TT</given-names>
          </name>
          <article-title>Kikuchi&#x2019;s disease (Histiocytic necrotizing lymphadenitis) A clinicopathologic study of 79 cases with an analysis of histologic subtypes, immunology, and DNA ploidy</article-title>
          <source>Am J Surg Pathol</source>
          <year>1995</year>
          <volume>19</volume>
          <fpage>798</fpage>
          <lpage>809</lpage>
          <pub-id pub-id-type="doi">10.1097/00000478-199507000-00008</pub-id>
          <pub-id pub-id-type="pmid">7793478</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Maeda</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Ashie</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Ishiyama</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Kikuiri</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Mori</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Shimamoto</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Fujisawa</surname>
            <given-names>Y</given-names>
          </name>
          <article-title>A case of necrotizing lymphadenitis associated with aseptic meningitis</article-title>
          <source>Nihon Naikagakkai Zasshi</source>
          <year>1987</year>
          <volume>76</volume>
          <fpage>1073</fpage>
          <lpage>1077</lpage>
          <pub-id pub-id-type="doi">10.2169/naika.76.1073</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Mathew</surname>
            <given-names>LG</given-names>
          </name>
          <name>
            <surname>Cherian</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Srivastava</surname>
            <given-names>VM</given-names>
          </name>
          <name>
            <surname>Raghupathy</surname>
            <given-names>P</given-names>
          </name>
          <article-title>Histiocytic Necrotizing Lymphadenitis (Kikuchi's Disease) with Aseptic Meningitis</article-title>
          <source>Indian Pediatr</source>
          <year>1998</year>
          <volume>35</volume>
          <fpage>775</fpage>
          <lpage>777</lpage>
          <pub-id pub-id-type="pmid">10216573</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Itokawa</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Fukui</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Nakazato</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Yamamoto</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Tamura</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Sannohe</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Shimazu</surname>
            <given-names>K</given-names>
          </name>
          <article-title>A case of subacute necrotizing lymphadenitis with recurrent aseptic meningitis 11 years after the first episode</article-title>
          <source>Clin Neurol</source>
          <year>2008</year>
          <volume>48</volume>
          <fpage>275</fpage>
          <lpage>277</lpage>
        </mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Yamashita</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Shibata</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Nagano</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Aishima</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Yoshimura</surname>
            <given-names>T</given-names>
          </name>
          <article-title>A case of subacute necrotizing lymphadenitis with recurrent aseptic meningitis associated with persistent high titer of anti-nuclear antibody occurring over a short period of time</article-title>
          <source>Clin Neurol</source>
          <year>2010</year>
          <volume>50</volume>
          <fpage>728</fpage>
          <lpage>731</lpage>
        </mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Kikuchi</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Lymphadenitis showing focal reticulum cell hyperplasia with nuclear debris and phagocytes</article-title>
          <source>Acta Hematol Jpn</source>
          <year>1972</year>
          <volume>35</volume>
          <fpage>379</fpage>
          <lpage>380</lpage>
        </mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Fujimoto</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Kojima</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Yamaguchi</surname>
            <given-names>K</given-names>
          </name>
          <article-title>Cervical subacute necrotizing lymphadenitis</article-title>
          <source>Naika</source>
          <year>1972</year>
          <volume>30</volume>
          <fpage>920</fpage>
          <lpage>927</lpage>
        </mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Bosch</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Guilabert</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Miquel</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Campo</surname>
            <given-names>E</given-names>
          </name>
          <article-title>Enigmatic Kikuchi-Fujimoto disease. A comprehensive review</article-title>
          <source>Am J Clin Pathol</source>
          <year>2004</year>
          <volume>122</volume>
          <fpage>141</fpage>
          <lpage>152</lpage>
          <pub-id pub-id-type="doi">10.1309/YF081L4TKYWVYVPQ</pub-id>
          <pub-id pub-id-type="pmid">15272543</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hollingsworth</surname>
            <given-names>HC</given-names>
          </name>
          <name>
            <surname>Peiper</surname>
            <given-names>SC</given-names>
          </name>
          <name>
            <surname>Weiss</surname>
            <given-names>LM</given-names>
          </name>
          <name>
            <surname>Raffeld</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Jaffe</surname>
            <given-names>ES</given-names>
          </name>
          <article-title>An investigation of the viral pathogenesis of Kikuchi-Fujimoto disease. Lack of evidence for Epstein-Barr virus or human herpesvirus type 6 as the causative agents</article-title>
          <source>Arch Pathol Lab Med</source>
          <year>1994</year>
          <volume>118</volume>
          <fpage>134</fpage>
          <lpage>140</lpage>
          <pub-id pub-id-type="pmid">8311651</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Colonna</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Trinchieri</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>YJ</given-names>
          </name>
          <article-title>Plasmacytoid dendritic cells in immunity</article-title>
          <source>Nat Immunol</source>
          <year>2004</year>
          <volume>5</volume>
          <fpage>1219</fpage>
          <lpage>1226</lpage>
          <pub-id pub-id-type="doi">10.1038/ni1141</pub-id>
          <pub-id pub-id-type="pmid">15549123</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Karageorgas</surname>
            <given-names>TP</given-names>
          </name>
          <name>
            <surname>Tseronis</surname>
            <given-names>DD</given-names>
          </name>
          <name>
            <surname>Mavragani</surname>
            <given-names>CP</given-names>
          </name>
          <article-title>Activation of type 1 interferon in systemic lupus erythematosus: association with distinct clinical phenotypes</article-title>
          <source>J Biomed Biotechnol</source>
          <year>2011</year>
          <volume>2011</volume>
          <fpage>273907</fpage>
          <pub-id pub-id-type="pmid">22162633</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
